Platelets and Vascular Thrombosis

Abstract

Heart attacks and strokes are usually caused by thrombo-occlusive events at sites of atherosclerotic stenosis and plaque rupture¹. These thrombotic processes are generally mediated by thrombin, dependent on the action of platelets, and not completely responsive to conventional therapy with aspirin and heparin^2,3. Resistant thrombi may also form after vascular procedures commonly performed for the treatment of symptomatic atherosclerotic disease, including coronary angioplasty, various types of atherectomy, placement of endovascular stents, endarterectomy, and implantation of small-caliber vascular grafts^4,5. In fact, abrupt vessel closure and coronary restenosis are the two most difficult problems limiting the success . . .